Method for generating primate cardiovascular progenitor cells for clinical use from primate embryonic stem cells or embryonic-like state cells, and their applications

Details for Australian Patent Application No. 2009224684 (hide)

Owner Assistance Publique - Hopitaux de Paris Institut National de la Sante et de la Recherche Medicale (INSERM) Universite Paris Descartes Universite Montpellier 2 Sciences et Techniques Universite Paris Diderot Paris 7

Inventors Nury, David; Puceat, Michel; Blin, Guillaume; Menasche, Philippe; Stefanovic, Sonia; Larghero, Jerome

Agent Freehills

Pub. Number AU-A-2009224684

PCT Pub. Number WO2009/112496

Priority 08300138.8 10.03.08 EP; 61/035,146 10.03.08 US

Filing date 10 March 2009

Wipo publication date 17 September 2009

International Classifications

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/112496 Priority application(s): WO2009/112496

21 April 2011 Assignment before Grant

  Universite Paris Diderot Paris 7; Universite Paris Descartes; Assistance Publique - Hopitaux de Paris; Universite Montpellier 2 Sciences et Techniques; Institut National de la Sante et de la Recherche Medicale (INSERM) The application has been assigned to Assistance Publique - Hopitaux de Paris; Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris Descartes; Universite Paris Diderot Paris 7

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009224690-Agent for treating disease

2009224681-Formulation and method for the prevention and treatment of bone metastases or other bone diseases